Japan Delays Deciding Whether To Expand Company-Operated Medical Institutions Nationwide
This article was originally published in PharmAsia News
Japan will delay until after 2008 deciding whether to expand medical institutions operated by companies nationwide. Currently, medical institutions operated by companies are allowed only in special zones, and the services are limited to using advanced medical technology and non-insurance coverage items. This has prevented prefectures other than Kanagawa Prefecture to apply for designation as a "special zone.
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.